Impact of Subcutaneous Specific-Allergen Immunotherapy in the Quality of Life of Brazilian Moderate/Severe Atopic Dermatitis Patients

World Allergy Organization Journal - United Kingdom
doi 10.1186/1939-4551-8-s1-a74